These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16958043)

  • 1. Rationally designed peptides for controlled release of nerve growth factor from fibrin matrices.
    Willerth SM; Johnson PJ; Maxwell DJ; Parsons SR; Doukas ME; Sakiyama-Elbert SE
    J Biomed Mater Res A; 2007 Jan; 80(1):13-23. PubMed ID: 16958043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release rate controls biological activity of nerve growth factor released from fibrin matrices containing affinity-based delivery systems.
    Wood MD; Sakiyama-Elbert SE
    J Biomed Mater Res A; 2008 Feb; 84(2):300-12. PubMed ID: 17607752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of rationally designed affinity-based drug delivery systems.
    Maxwell DJ; Hicks BC; Parsons S; Sakiyama-Elbert SE
    Acta Biomater; 2005 Jan; 1(1):101-13. PubMed ID: 16701784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled release of glial-derived neurotrophic factor from fibrin matrices containing an affinity-based delivery system.
    Wood MD; Borschel GH; Sakiyama-Elbert SE
    J Biomed Mater Res A; 2009 Jun; 89(4):909-18. PubMed ID: 18465825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury.
    Taylor SJ; McDonald JW; Sakiyama-Elbert SE
    J Control Release; 2004 Aug; 98(2):281-94. PubMed ID: 15262419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa.
    Schense JC; Hubbell JA
    Bioconjug Chem; 1999; 10(1):75-81. PubMed ID: 9893967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release of nerve growth factor from fibrin gel.
    Bhang SH; Jeon O; Choi CY; Kwon YH; Kim BS
    J Biomed Mater Res A; 2007 Mar; 80(4):998-1002. PubMed ID: 17117469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix.
    Sakiyama-Elbert SE; Hubbell JA
    J Control Release; 2000 Oct; 69(1):149-58. PubMed ID: 11018553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary cinemicrographic study on the effect of NGF on the growth of chick embryonic sensory neurites in vitro.
    Blood LA
    Neurobiology; 1973; 3(2):53-65. PubMed ID: 16100955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect of GDNF and NGF on axonal branching and elongation in vitro.
    Madduri S; Papaloïzos M; Gander B
    Neurosci Res; 2009 Sep; 65(1):88-97. PubMed ID: 19523996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silk fibroin matrices for the controlled release of nerve growth factor (NGF).
    Uebersax L; Mattotti M; Papaloïzos M; Merkle HP; Gander B; Meinel L
    Biomaterials; 2007 Oct; 28(30):4449-60. PubMed ID: 17643485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mesoporous silica nanosphere-based drug delivery system using an electrically conducting polymer.
    Cho Y; Shi R; Ivanisevic A; Ben Borgens R
    Nanotechnology; 2009 Jul; 20(27):275102. PubMed ID: 19528680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of fibrin derivatives for controlled release of heparin-binding growth factors.
    Sakiyama-Elbert SE; Hubbell JA
    J Control Release; 2000 Apr; 65(3):389-402. PubMed ID: 10699297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel peptide ligand of human vascular endothelia growth factor receptor 3 for targeted tumour diagnosis and therapy.
    Qin X; Wan Y; Li M; Xue X; Wu S; Zhang C; You Y; Wang W; Jiang C; Liu Y; Zhu W; Ran Y; Zhang Z; Han W; Zhang Y
    J Biochem; 2007 Jul; 142(1):79-85. PubMed ID: 17517791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-viral gene delivery for local and controlled DNA release.
    Trentin D; Hubbell J; Hall H
    J Control Release; 2005 Jan; 102(1):263-75. PubMed ID: 15653151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
    Sugaya M; Nishino N; Katoh A; Harada K
    J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity-based screening of peptides recognizing assembly states of self-assembling peptide nanomaterials.
    Sawada T; Takahashi T; Mihara H
    J Am Chem Soc; 2009 Oct; 131(40):14434-41. PubMed ID: 19764764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Siatic nerve regeneration in rats stimulated by fibrin glue containing nerve growth factor: an experimental study.
    Gao C; Ma S; Ji Y; Wang JE; Li J
    Injury; 2008 Dec; 39(12):1414-20. PubMed ID: 18715558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel peptide isolated from phage display peptides library recognized by an antibody against connective tissue growth factor (CTGF).
    Liu N; Wu G; Li H; Li L; Xing H; Zhang C; Lu H
    Int Immunopharmacol; 2009 Mar; 9(3):291-7. PubMed ID: 19103307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of nerve growth factor from HEMA hydrogel-coated substrates and its effect on the differentiation of neural cells.
    Jhaveri SJ; Hynd MR; Dowell-Mesfin N; Turner JN; Shain W; Ober CK
    Biomacromolecules; 2009 Jan; 10(1):174-83. PubMed ID: 19061335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.